BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 27, 2003
View Archived Issues
Vical enters CRADA for West Nile virus vaccine development
Read More
Crucell malaria vaccine candidate to be evaluated in two collaborative programs
Read More
Ranbaxy and GSK enter drug discovery and development collaboration
Read More
Two series of alpha7 nAChR agonists prepared and tested at Bayer
Read More
New synthetic pateamine A analogues and their use as immunosuppressant agents
Read More
Novel HIV protease inhibitors developed by U. of Illinois researchers
Read More
Ariad describes bone antiresorptive proteasome inhibitors and their use
Read More
Quinoline-based PDE4 inhibitors and their use covered by Merck Frosst patent
Read More
New mGluR5 antagonists identified by Merck researchers
Read More
Merck claims new androgen receptor modulators for osteoporosis and other disorders
Read More
Positive results reported for ABR-215757 in a murine model of systemic lupus erythematosus
Read More
SB-431542, a potent inhibitor of TGF-beta signaling
Read More
New COX-2 inhibitor from Almirall effective in animal models of arthritis
Read More
BIRB-796, a p38 MAP kinase inhibitor, blocks both kinase activation and kinase activity
Read More
The synthetic chalcone AGI-2048 shows promise as an oral DMARD for RA
Read More
Met-RANTES, a CC chemokine receptor antagonist, shows activity in rat arthritis model
Read More
Alpha-lipoic acid found to suppress joint inflammation and destruction in murine arthritis
Read More
mTOR inhibitor RAD-001 in antibody-mediated autoimmunity
Read More
Top-line results from third phase III study of Entereg for postoperative ileus
Read More
Positive opinion handed down by CPMP for Advate
Read More
CETi-1 produces increase in HDL cholesterol in phase II trial
Read More
Dyax and URRMA enter alliance to develop anti-R7V antibodies for HIV
Read More
Avandamet approved in E.U.
Read More
Starlix approved in combination with TZD for type 2 diabetes
Read More
Yondelis receives E.U. orphan drug status for ovarian cancer
Read More
Roche and Nippon Shinyaku to develop drugs for dyslipidemia
Read More
Remicade approved in E.U. for maintenance dosing in fistulizing Crohn's disease
Read More
Preclinical studies support further development of MB-7133 for HCC
Read More